News -CureApp, Inc.

We are pleased to inform you that the article has been published with the approval of our Nicotine Addiction Treatment App With CO Checker.   Bio Space Asia’s First Prescription “Digital Therapeutic” Approved in Japan; Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc.   https://www.biospace.com/article/releases/asia-s-first-prescription-digital-therapeutic-approved-in-japan-nicotine-addiction-treatment-app-with-co-checker-receives-regulatory-approval-cureapp-inc-/?s=85&utm_source=dlvr.it&utm_medium=twitter

  Entering a New Age Where Innovative Treatments Are Provided With an App Asia’s First Prescription “Digital Therapeutic” Approved in Japan Nicotine Addiction Treatment App with CO Checker Receives Regulatory Approval The World’s First App-based Nicotine Addiction Treatment     CureApp, Inc. (Headquarter: Chuo-ku, Tokyo; CEO: Kohta Satake) received regulatory authorization for the manufacturing and sale of Asia’s first therapeutics app, the “CureApp SC Nicotine Addiction Treatment App and CO Checker” (hereafter, CureApp SC), from the Ministry of Health, Labour and Welfare (MHLW) on August 21st, 2020. The Company is currently proceeding with plans to receive insurance reimbursement and release CureApp SC in FY2020. CureApp SC 　CureApp SC is a prescription medical device designed to aid patients who are receiving outpatient smoking cessation treatment. The device supports patients in their attempt to quit smoking in a home setting. 　The product consists of three components - a patient ap

CureApp Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups  CureApp recognized for achievements in develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs or devices were not effective   NEW YORK, August 13, 2020 -- CB Insights today named CureApp to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others. “This year’s Digital Health 150 is our most global ever, covering the best private healthcare compa

We are pleased to inform you that our article has been published on Smart Industry News titled "Digital Therapeutics will Become a Major Treatment Option in the Future: Kohta Satake, CEO of CureApp." https://www.smartindustrynews.com/sin-article/digital-therapeutics-will-become-a-major-treatment-option-in-the-future-kohta-satake-ceo-of-cureapp/